Resources
About Us
Home Report
Store
Mice Model Market
Mice Model Market By Mice Type (Inbred, Hybrid), Services (Breeding, Cryopreservation, Quarantine), Technology (CRISPR, Nuclear Transfer), Application (Oncology, Cardiology, Neuro), End User (Research, Academia, Pharmaceutical) - Global Forecast to 2030
Report ID:MRHC - 10440 Pages: 180 May-2023 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe Mice Model Market is projected to reach $2.48 billion by 2030, at a CAGR of 6.5% from 2023 to 2030. Mice models are commonly used for studying aspects of human health & diseases. Mice are especially useful for this purpose since they have similar mammalian features to that of humans. There are different types of mice models, such as inbred mice, genetically engineered mice, hybrid/congenic mice, and conditioned/surgically modified mice. These models can be used for various applications, such as oncology, cardiology, genetic, and endocrine and metabolic studies.
The growth of this market is driven by factors such as the advantages of mice as an animal model for studying human diseases, the rising prevalence of cancer, the increasing number of grants for research studies, and the rising demand for personalized medicine. In addition, the technological advancements & innovations in mice models are expected to provide significant growth opportunities for this market.
However, ethical concerns and regulatory restrictions are expected to hinder the growth of this market to a certain extent. In addition, factors such as the lack of skilled personnel for performing animal studies and the high cost of mice models are the major challenges to the growth of this market.
Advantages of Mice as an Animal Model for Studying Human Diseases to Drive Market Growth
The mice models are the most preferred animals for research in laboratories. The genetic composition of humans and mice is very similar. In addition, the pathophysiology of diseases in mice is also similar to humans. Due to this, it is very easy and effective to conduct studies on mice models for research and drug testing.
Mice can also be genetically modified to mimic human diseases or conditions. These genetically modified mice can then be used to study the disease and test drugs on it. Additionally, mice have an accelerated life span compared to humans; due to this, the entire life cycle of mice can be studied in 2–3 years. Some other advantages they offer are cost-effectiveness; they are easy to handle, transport, and reproduce.
Thus, the advantages of mice as an animal model for studying human diseases are expected to drive the growth of the mice model market.
Click here to: Get a Free Sample Copy of this report
Increasing Prevalence of Cancer to Drive Demand for Mice Models in Cancer Research
Cancer has been one of the most complex and expensive diseases globally, with a huge economic burden on many countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetimes, with 1 in 8 men and 1 in 11 women dying from the disease.
Cancer is a major cause of death and a prominent obstacle to improving life expectancy in every country worldwide. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases is expected to reach 24.5 million by 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million by 2030.
Mice models can be used to identify the genetic causes of cancer, reproduce tumor types in mice and test new cancer therapies. Thus, the increasing prevalence of cancer is driving the use of mice models in cancer research.
Key Findings of the Mice Model Market Study:
In 2023, the Inbred Mice Segment is Expected to Dominate the Mice Model Market
Based on mice type, the mice model market is segmented into inbred mice, genetically engineered mice, outbred mice, hybrid/ congenic mice, conditioned/surgically modified mice, spontaneous mutant mice, and other types. In 2023, the inbred mice segment is expected to account for the largest share of the mice model market. Inbred mice are colonies produced by mating twenty or more generations of brother-sister pairs. This mating provides mice that are genetically identical within each inbred strain. The large market share of this segment is attributed to the increased use of inbred mice due to their advantages, such as unique and stable phenotypic traits, consistency in the test results, and predictable experiment response.
In 2023, the Breeding Segment is Expected to Dominate the Mice Model Market
Based on service, the mice model market is segmented into breeding, cryopreservation, model-in licensing, genetic testing, quarantine, and other services. In 2023, the breeding segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the increased demand for breeding services for providing genetically modified mice strains, the increasing number of research projects and research funding.
In 2023, the CRISPR/CAS9 Segment is Expected to Dominate the Mice Model Market
Based on technology, the mice model market is segmented into CRISPR/CAS9, embryonic stem cell injection, nuclear transfer, and other technologies. In 2023, the CRISPR/CAS9 segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the advantages of using this technology in genome editing for creating unique mouse models of human disease. This technology can produce mice models in a cost-effective way while saving time and potentially reducing the number of animal usage.
In 2023, the Outsourced Segment is Expected to Dominate the Mice Model Market
Based on mode, the mice model market is segmented into outsourced and in-house. In 2023, the outsourced segment is expected to account for the larger share of the mice model market. The large market share of this segment is attributed to the advantages of outsourcing mice models, such as cost savings, increased flexibility, access to specialized expertise, and availability of a large variety of models.
In 2023, the Oncology Studies Segment is Expected to Dominate the Mice Model Market
Based on application, the mice model market is segmented into oncology studies, cardiovascular studies, genetic studies, endocrine metabolic studies, neurological studies, immunology & inflammation studies, and other applications. In 2023, the oncology studies segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the increased prevalence of cancer, increased funding for cancer research, and advantages of using mice models in cancer research, such as the ability to physiologically imitate cancer as humans.
In 2023, the Pharmaceutical & Biotechnology Companies Segment is Expected to Dominate the Mice Model Market
Based on end user, the mice model market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. In 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the mice model market. The large market share of this segment is attributed to the increased global pharmaceutical R&D expenditure, rising demand for personalized medicine, and a large number of therapeutic drug molecules in the research pipeline.
Asia-Pacific: The Fastest-growing Regional Market
Asia-Pacific is slated to record the highest CAGR in the mice model market during the forecast period. The growth of this market is driven by the rapidly growing pharmaceutical & biotechnology industry in the region, increasing R&D expenditure, and increasing government funding for research projects, especially in China and India.
Key Players
The report includes a competitive landscape based on an extensive assessment of the market based on mice type, service, technology, mode, application, end user, and geography. The report also provides insights into the geographic presence of major market players and their key growth strategies in the last three to four years.
The key players profiled in the mice model market are Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Laboratory Corporation of America Holdings (U.S.), Horizon Discovery Group plc (U.K.), Trans Genic Inc. (Japan), GenOway S.A. (France), Taconic Biosciences, Inc.(U.S.), Envigo Ltd (U.S.), Janvier Labs (France), ingenious targeting laboratory (U.S.), Harbour Antibodies B.V. (China) (Subsidiary of HBM Holdings), Crescendo Biologics Ltd. (U.K.), Deltagen Inc. (U.S.), and ImmunoGenes Kft. (Hungary).
Scope of the Report:
Mice Model Market Assessment, by Mice Type
- Inbred Mice
- Genetically Engineered Mice
- Outbred Mice
- Hybrid/Congenic Mice
- Conditioned/Surgically Modified Mice
- Spontaneous Mutant Mice
- Other Types
(Other types majorly include knockout mice model, carcinogen-induced mice model, and transplantation mice model)
Mice Model Market Assessment, by Service
- Breeding
- Cryopreservation
- Model-in Licensing
- Genetic Testing
- Quarantine
- Other Services
(Other Services include in-vivo & in-vitro pharmacology, rederivation, and genetically engineered model services)
Mice Model Market Assessment, by Technology
- CRISPR/CAS9
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Other Technologies
(Other Technologies majorly include microinjection and chemical mutagenesis)
Mice Model Market Assessment, by Mode
- Outsourced
- In-house
Mice Model Market Assessment, by Application
- Oncology Studies
- Cardiovascular Studies
- Genetic Studies
- Endocrine Metabolic Studies
- Neurological Studies
- Immunology & Inflammation studies
- Other Applications
(Other applications include infectious disease studies, fibrosis, and regenerative medicine)
Mice Model Market Assessment, by End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
- Other End Users
(Other end users include cosmetic companies and government agencies)
Mice Model Market, by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America (RoLATAM)
- Middle East & Africa
Key questions answered in the report:
This market study covers the market sizes & forecasts of the mice model market based on mice type, services technology, mode, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the mice model market at the regional and country levels.
The mice model market is projected to reach $2.48 billion by 2030, at a CAGR of 6.5% during the forecast period of 2023–2030.
What are the various types of mice models, and which mice type segment holds the major share market?
Based on mice type, the mice model market is segmented into inbred mice, genetically engineered mice, outbred mice, hybrid/ congenic mice, conditioned/surgically modified mice, spontaneous mutant mice, and other types. In 2023, the inbred mice segment is expected to account for the largest share of the mice model market due to the high demand for inbred mice due to its advantages, such as consistency in the test results, unique and stable phenotypic traits, and predictable experiment response.
Based on service, the mice model market is segmented into breeding, cryopreservation, model-in licensing, genetic testing, quarantine, and other services. In 2023, the breeding segment is expected to account for the largest share of the mice model market due to the high demand for breeding services for producing genetically modified mice that can produce consistent and statistically appropriate results for a research study.
Based on technology, the mice model market is segmented into CRISPR/CAS9, embryonic stem cell injection, nuclear transfer, and other technologies. In 2023, the CRISPR/CAS9 segment is expected to account for the largest share of the mice model market due to the advantages of using this technology in genome editing for creating unique mouse models of human disease, such as shorter timelines, lower costs, and the capacity to alter multiple genes simultaneously.
Based on mode, the mice model market is segmented into outsourced and in-house. In 2023, the outsourced segment is expected to account for the larger share of the mice model market. The large market share of this segment is attributed to the advantages of outsourcing mice models, such as the availability of a large variety of models, increased flexibility, cost savings, and access to specialized expertise.
Based on application, the mice model market is segmented into oncology studies, cardiovascular studies, genetic studies, endocrine metabolic studies, neurological studies, immunology & inflammation studies, and other applications. In 2023, the oncology studies segment is expected to account for the largest share of the mice model market attributed to the increased funding for cancer research, increased prevalence of cancer, and advantages of using mice model in cancer research, such as the ability to physiologically imitate cancer similar to humans.
Based on end user, the mice model market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users. In 2023, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the mice model market attributed to the growing demand for personalized medicine, increased global pharmaceutical R&D expenditure, and a large number of therapeutic drug molecules in the research pipeline.
The growth of this market is driven by factors such as the advantages of mice as an animal model for studying human diseases, the rising prevalence of cancer, the increasing number of grants for research studies, and the rising demand for personalized medicine. In addition, the technological advancements & innovations in mice models are expected to provide significant growth opportunities for this market.
However, ethical concerns and regulatory restrictions are expected to hinder the growth of this market to a certain extent. In addition, factors such as the Lack of skilled personnel for performing animal studies and the high cost of mice models are the major challenges to the growth of this market.
The key players operating in the mice model market are Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Laboratory Corporation of America Holdings (U.S.), Horizon Discovery Group plc (U.K.), Trans Genic Inc. (Japan), GenOway S.A. (France), Taconic Biosciences, Inc.(U.S.), Envigo Ltd (U.S.), Janvier Labs (France), ingenious targeting laboratory (U.S.), Harbour Antibodies B.V. (China) (Subsidiary of HBM Holdings), Crescendo Biologics Ltd. (U.K.), Deltagen Inc. (U.S.), and ImmunoGenes Kft. (Hungary).
Asia-Pacific is slated to register the highest CAGR during the forecast period and offer significant growth opportunities for the players in this market. The high market growth in Asia-Pacific is driven by the rapidly growing pharmaceutical & biotechnology industry in the region, increasing R&D expenditure, and increasing government funding for research projects, especially in China and India.
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Advantages of Mice as an Animal Model for Studying Human Diseases
4.2.2. Rising Prevalence of Cancer
4.2.3. Increasing Number of Grants for Research Studies
4.2.4. Rising Demand for Personalized Medicine
4.3. Restraints
4.3.1. Ethical Concerns
4.3.2. Regulatory Restrictions
4.4. Opportunity
4.4.1. Technological Advancements & Innovations in Mice Models
4.5. Challenges
4.5.1. Lack of Skilled Personnel for Performing Animal Studies
4.5.2. High Cost of Mice Models
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Industry & Technological Trends
5. Global Mice Models Market Assessment—by Mice Type
5.1. Overview
5.2. Inbred Mice
5.3. Genetically Engineered Mice
5.4. Outbred Mice
5.5. Hybrid/ Congenic Mice
5.6. Conditioned/Surgically Modified Mice
5.7. Spontaneous Mutant Mice
5.8. Other Mice Types
6. Global Mice Models Market Assessment—by Service
6.1. Overview
6.2. Breeding
6.3. Cryopreservation
6.4. Model-in Licensing
6.5. Genetic Testing
6.6. Quarantine
6.7. Other Services
7. Global Mice Models Market Assessment—by Technology
7.1. Overview
7.2. CRISPR/CAS9
7.3. Embryonic Stem Cell Injection
7.4. Nuclear Transfer
7.5. Other Technologies
8. Global Mice Models Market Assessment—by Mode
8.1. Overview
8.2. Outsourced
8.3. In-house
9. Global Mice Models Market Assessment—by Application
9.1. Overview
9.2. Oncology Studies
9.3. Cardiovascular Studies
9.4. Genetic Studies
9.5. Endocrine Metabolic Studies
9.6. Neurological Studies
9.7. Immunology & Inflammation Studies
9.8. Other Applications
10. Global Mice Models Market Assessment—by End User
10.1. Overview
10.2. Pharmaceutical & Biotechnology Companies
10.3. Academic & Research Institutes
10.4. Contract Research Organizations
10.5. Other End Users
11. Mice Models Market Assessment—by Geography
11.1. Overview
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa
12. Competition Analysis
12.1. Overview
12.2. Key Growth Strategies
12.3. Vendor Benchmarking
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share Analysis (2022)
13. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis*)
13.1. Charles River Laboratories International, Inc.
13.2. The Jackson Laboratory
13.3. Laboratory Corporation of America Holdings
13.4. Horizon Discovery Group plc
13.5. Trans Genic Inc.
13.6. GenOway S.A.
13.7. Taconic Biosciences, Inc.
13.8. Envigo Ltd
13.9. Janvier Labs
13.10. ingenious targeting laboratory
13.11. Harbour Antibodies B.V. (Subsidiary of HBM Holdings)
13.12. Crescendo Biologics Ltd.
13.13. Deltagen Inc.
13.14. ImmunoGenes Kft.
14. Appendix
14.1. Available Customization
14.2. Related Reports
List of Tables
Table 1 Global Mice Models Market Drivers: Impact Analysis (2023–2030)
Table 2 Global Mice Models Market Restraints: Impact Analysis (2023–2030)
Table 3 Global Mice Models Market Opportunities: Impact Analysis (2023–2030)
Table 4 Global Mice Models Market Challenges: Impact Analysis (2023–2030)
Table 5 Global Mice Models Market, by Mice Type, 2021–2030 (USD Million)
Table 6 Global Inbred Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Genetically Engineered Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Outbred Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Hybrid/Congenic Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Conditioned/Surgically Modified Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Spontaneous Mutant Mice Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Other Mice Types Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Mice Models Market, by Service, 2021–2030 (USD Million)
Table 14 Global Mice Models Market for Breeding Services, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Mice Models Market for Cryopreservation Services, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Mice Models Market for Model-in Licensing Services, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Mice Models Market for Genetic Testing Services, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Mice Models Market for Quarantine Services, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Mice Models Market for Other Services, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 21 Global Mice Models Market for CRISPR/CAS9, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Mice Models Market for Embryonic Stem Cell Injection, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Mice Models Market for Nuclear Transfer, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Mice Models Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 26 Global Outsourced Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 27 Global In-house Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 28 Global Mice Models Market, by Application, 2021–2030 (USD Million)
Table 29 Global Mice Models Market for Oncology Studies, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Mice Models Market for Cardiovascular Studies, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Mice Models Market for Genetic Studies, by Country/Region, 2021–2030 (USD Million)
Table 32 Global Mice Models Market for Endocrine Metabolic Studies, by Country/Region, 2021–2030 (USD Million)
Table 33 Global Mice Models Market for Neurological Studies, by Country/Region, 2021–2030 (USD Million)
Table 34 Global Mice Models Market for Immunology & Inflammation studies, by Country/Region, 2021–2030 (USD Million)
Table 35 Global Mice Models Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 36 Global Mice Models Market, by End User, 2021–2030 (USD Million)
Table 37 Global Mice Models Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 38 Global Mice Models Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 39 Global Mice Models Market for Contract Research Organizations, by Country/Region, 2021–2030 (USD Million)
Table 40 Global Mice Models Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 41 Global Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 42 North America: Mice Models Market, by Country, 2021–2030 (USD Million)
Table 43 North America: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 44 North America: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 45 North America: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 46 North America: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 47 North America: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 48 North America: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 49 U.S.: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 50 U.S.: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 51 U.S.: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 52 U.S.: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 53 U.S.: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 54 U.S.: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 55 Canada: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 56 Canada: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 57 Canada: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 58 Canada: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 59 Canada: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 60 Canada: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 61 Europe: Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 62 Europe: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 63 Europe: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 64 Europe: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 65 Europe: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 66 Europe: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 67 Europe: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 68 Germany: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 69 Germany: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 70 Germany: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 71 Germany: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 72 Germany: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 73 Germany: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 74 U.K.: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 75 U.K.: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 76 U.K.: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 77 U.K.: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 78 U.K.: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 79 U.K.: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 80 France: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 81 France: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 82 France: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 83 France: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 84 France: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 85 France: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 86 Spain: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 87 Spain: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 88 Spain: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 89 Spain: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 90 Spain: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 91 Spain: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 92 Italy: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 93 Italy: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 94 Italy: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 95 Italy: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 96 Italy: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 97 Italy: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 98 Rest of Europe: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 99 Rest of Europe: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 100 Rest of Europe: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 101 Rest of Europe: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 102 Rest of Europe: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 103 Rest of Europe: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 104 Asia-Pacific: Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 105 Asia-Pacific: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 106 Asia-Pacific: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 107 Asia-Pacific: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 108 Asia-Pacific: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 109 Asia-Pacific: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 110 Asia-Pacific: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 111 China: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 112 China: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 113 China: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 114 China: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 115 China: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 116 China: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 117 Japan: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 118 Japan: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 119 Japan: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 120 Japan: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 121 Japan: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 122 Japan: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 123 India: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 124 India: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 125 India: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 126 India: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 127 India: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 128 India: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 129 Rest of Asia-Pacific: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 130 Rest of Asia-Pacific: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 131 Rest of Asia-Pacific: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 132 Rest of Asia-Pacific: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 133 Rest of Asia-Pacific: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 134 Rest of Asia-Pacific: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 135 Latin America: Mice Models Market, by Country/Region, 2021–2030 (USD Million)
Table 136 Latin America: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 137 Latin America: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 138 Latin America: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 139 Latin America: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 140 Latin America: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 141 Latin America: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 142 Brazil: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 143 Brazil: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 144 Brazil: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 145 Brazil: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 146 Brazil: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 147 Brazil: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 148 Mexico: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 149 Mexico: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 150 Mexico: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 151 Mexico: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 152 Mexico: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 153 Mexico: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 154 Rest of Latin America: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 155 Rest of Latin America: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 156 Rest of Latin America: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 157 Rest of Latin America: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 158 Rest of Latin America: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 159 Rest of Latin America: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 160 Middle East & Africa: Mice Models Market, by Mice Type 2021–2030 (USD Million)
Table 161 Middle East & Africa: Mice Models Market, by Service, 2021–2030 (USD Million)
Table 162 Middle East & Africa: Mice Models Market, by Technology, 2021–2030 (USD Million)
Table 163 Middle East & Africa: Mice Models Market, by Mode, 2021–2030 (USD Million)
Table 164 Middle East & Africa: Mice Models Market, by Application, 2021–2030 (USD Million)
Table 165 Middle East & Africa: Mice Models Market, by End User, 2021–2030 (USD Million)
Table 166 Recent Developments, by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Mice Models Market Size, by Mice Type, 2023 Vs. 2030 (USD Million)
Figure 8 Global Mice Models Market Size, by Service, 2023 Vs. 2030 (USD Million)
Figure 9 Global Mice Models Market Size, by Technology, 2023 Vs. 2030 (USD Million)
Figure 10 Global Mice Models Market Size, by Mode, 2023 Vs. 2030 (USD Million)
Figure 11 Global Mice Models Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 12 Global Mice Models Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 13 Global Mice Models Market Size, by Geography
Figure 14 Market Dynamics: Mice Model Market
Figure 15 Global Mice Models Market Size, by Mice Type, 2023 Vs. 2030 (USD Million)
Figure 16 Global Mice Models Market Size, by Service, 2023 Vs. 2030 (USD Million)
Figure 17 Global Mice Models Market Size, by Technology, 2023 Vs. 2030 (USD Million)
Figure 18 Global Mice Models Market Size, by Mode, 2023 Vs. 2030 (USD Million)
Figure 19 Global Mice Models Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 20 Global Mice Models Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 21 Global Mice Models Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Mice Models Market Snapshot
Figure 23 Europe: Mice Models Market Snapshot
Figure 24 Asia Pacific: Mice Models Market Snapshot
Figure 25 Latin America: Mice Models Market Snapshot
Figure 26 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 27 Global Mice Models Market: Vendor Benchmarking Based on Mice Type
Figure 28 Global Mice Models Market: Vendor Benchmarking Based on Geography
Figure 29 Global Mice Models Market: Competitive Dashboard
Figure 30 Market Share Analysis: Mice Models Market (2022)
Figure 31 Charles River Laboratories International, Inc.: Financial Overview (2022)
Figure 32 Laboratory Corporation of America Holdings: Financial Overview (2022)
Figure 33 Horizon Discovery Group plc: Financial Overview (2022)
Figure 34 Trans Genic Inc.: Financial Overview (2022)
Figure 35 GenOway S.A.: Financial Overview (2022)
Figure 36 HBM Holdings: Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Antibody Production Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
3D Cell Culture Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jul-2023
